Pharmaceuticals in New Zealand

MarketLine
April 30, 2014
33 Pages - SKU: MTLN5250284
Countries covered: New Zealand

Pharmaceuticals in New Zealand

Introduction

Pharmaceuticals in New Zealand industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the New Zealand pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.
  • The New Zealand pharmaceuticals market had total revenues of $1.0bn in 2013, representing a compound annual growth rate (CAGR) of 2.9% between 2009 and 2013.
  • The performance of the market is forecast to decelerate, with an anticipated CAGR of 1.3% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $1.1bn by the end of 2018.
  • Despite the expected deceleration in the market, the expanding and ageing population in New Zealand, coupled with high government spending, is likely to help the market maintain positive growth in the long term.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in New Zealand

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in New Zealand

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the New Zealand pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the New Zealand economy

Key Questions Answered

What was the size of the New Zealand pharmaceuticals market by value in 2013?

What will be the size of the New Zealand pharmaceuticals market in 2018?

What factors are affecting the strength of competition in the New Zealand pharmaceuticals market?

How has the market performed over the last five years?Who are the top competitiors in New Zealand's pharmaceuticals market?



More Manufacturing, Packaging & Detailing reports by MarketLine

Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry Guide by MarketLine
Pharmaceuticals: BRIC (Brazil, Russia, India, China) Industry GuideIntroductionThe BRIC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and ...
Pharmaceuticals: North America (NAFTA) Industry Guide by MarketLine
Pharmaceuticals: North America (NAFTA) Industry GuideIntroductionThe NAFTA Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to ...
Pharmaceuticals: Global Group of Eight (G8) Industry Guide by MarketLine
Pharmaceuticals: Global Group of Eight (G8) Industry GuideIntroductionThe G8 Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and ...
Pharmaceuticals: Global Industry Guide by MarketLine
Pharmaceuticals: Global Industry GuideIntroductionGlobal Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market size (value 2009-13, and forecast to 2018). The guide ...
See all reports like this >>

More New Zealand Manufacturing, Packaging & Detailing reports

New Zealand Pharmaceuticals and Healthcare - Report Q4 2014 by Business Monitor International
New Zealand Pharmaceuticals and Healthcare - Report Q4 2014BMI View: Limited pharmaceutical reimbursement in New Zealand will remain a key issue for innovativepharmaceutical firms as ...
Healthcare, Regulatory and Reimbursement Landscape - New Zealand by GlobalData
Healthcare, Regulatory and Reimbursement Landscape - New Zealand Summary GlobalData, the industry analysis specialist, has released its new report, “Healthcare, Regulatory and Reimbursement ...
New Zealand Pharmaceuticals and Healthcare Report Q1 2013 by Business Monitor International
BMI View: Low growth potential in New Zealand's pharmaceutical market will attract risk-averseinvestors. However, we note that regulatory delays in funding new medicines will hinder ...
New Zealand Pharmaceuticals and Healthcare Report Q4 2012 by Business Monitor International
BMI View: Strained public finances and a resultant focus on cost containment is expected to feed through into weak growth for New Zealand’s pharmaceutical market. ...
See all reports like this >>

More New Zealand reports

D&B Country RiskLine Report: New Zealand by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: New Zealand by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 350  
    Global Site License  USD 875  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!